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Blockade of the PI-3K Signalling Pathway by the Aggregatibacter
Actinomycetemcomitans Cytolethal Distending Toxin Induces Macrophages to
Synthesize and Secrete Pro-Inflammatory Cytokines
Abstract
The Aggregatibactor actinomycetemcomitans cytolethal distending toxin (Cdt) induces G2 arrest and
apoptosis in lymphocytes; these toxic effects are due to the active subunit, CdtB, which functions as a
phosphatidylinositol-3,4,5-triphosphate (PIP3) phosphatase. We now extend our investigation and
demonstrate that Cdt is able to perturb human macrophage function. THP-1- and monocyte-derived
macrophages were found not to be susceptible to Cdt-induced apoptosis. Nonetheless, the toxin was
capable of binding to macrophages and perturbing PI-3K signalling resulting in decreased PIP3 levels and
reduced phosphorylation of Akt and GSK3β these changes were accompanied by concomitant alterations
in kinase activity. Exposure of monocytes and macrophages to Cdt resulted in pro-inflammatory cytokine
production including increased expression and release of IL-1β, TNFα and IL-6. Furthermore, treatment of
cells with either TLR-2, -3 or -4 agonists in the presence of Cdt resulted in an augmented pro-inflammatory
response relative to agonist alone. GSK3β inhibitors blocked the Cdt-induced pro-inflammatory cytokine
response suggesting a pivotal role for PI-3K blockade, concomitant decrease in GSK3β phosphorylation
and increased kinase activity. Collectively, these studies provide new insight into the virulence potential of
Cdt in mediating the pathogenesis of disease caused by Cdt-producing organisms. © 2014 John Wiley &
Sons Ltd.
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Blockade of the PI-3K signalling pathway by the
Aggregatibacter actinomycetemcomitans cytolethal
distending toxin induces macrophages to synthesize
and secrete pro-inflammatory cytokines
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Summary
The Aggregatibactor actinomycetemcomitans
cytolethal distending toxin (Cdt) induces G2
arrest and apoptosis in lymphocytes; these
toxic effects are due to the active subunit, CdtB,
which functions as a phosphatidylinositol-3,4,5triphosphate (PIP3) phosphatase. We now extend
our investigation and demonstrate that Cdt is able
to perturb human macrophage function. THP-1and monocyte-derived macrophages were found
not to be susceptible to Cdt-induced apoptosis.
Nonetheless, the toxin was capable of binding
to macrophages and perturbing PI-3K signalling
resulting in decreased PIP3 levels and reduced
phosphorylation of Akt and GSK3β; these changes
were accompanied by concomitant alterations
in kinase activity. Exposure of monocytes and
macrophages to Cdt resulted in pro-inflammatory
cytokine production including increased expression and release of IL-1β, TNFα and IL-6. Furthermore, treatment of cells with either TLR-2, -3 or
-4 agonists in the presence of Cdt resulted in an
augmented pro-inflammatory response relative
to agonist alone. GSK3β inhibitors blocked the
Cdt-induced pro-inflammatory cytokine response
suggesting a pivotal role for PI-3K blockade,
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concomitant decrease in GSK3β phosphorylation
and increased kinase activity. Collectively, these
studies provide new insight into the virulence
potential of Cdt in mediating the pathogenesis of
disease caused by Cdt-producing organisms.
Introduction
The innate immune system is the first line of host defence
against microbial pathogens. Toll-like receptors (TLRs)
trigger innate immune reactions in response to microbial
products leading to the production of a number of
pro-inflammatory cytokines. These responses, by and
large, are considered to be protective, however, under
conditions of excessive or prolonged cytokine production can lead to inflammation and associated
tissue damage. Phosphatidylinositol-3-kinase (PI-3K), a
lipid kinase, phosphorylates phosphatidylinositol-4,5diphosphate (PI-4,5-P2) generating phosphatidylinositol3,4,5-triphosphate (PIP3). Generation of PIP3 at the
plasmalemma promotes the recruitment and phosphorylation of Akt and a number of downstream targets. The
PI-3K signalling cascade has been implicated as a regulator of the pro-inflammatory response, in general, and
TLR signalling, in particular, with contradictory roles. TLRassociated activation of PI-3K is a common feature in
macrophages (reviewed in Hazeki et al., 2007); however,
this means of activation is moderate at best demonstrating
low levels of activation compared to that commonly
observed with other types of PI-3K stimulation. In contrast,
the PI-3K signalling pathway is also proposed to be a
negative feedback regulator of TLR-mediated activation
that serves to suppress excessive macrophage responses
by inhibiting pro-inflammatory cytokine production and
augmenting anti-inflammatory responses (Fang et al.,
2004; Pengal et al., 2006; Lee et al., 2007; Tachado et al.,
2008; Antoniv and Ivashkiv, 2011; Hochdorfer et al., 2011).
A key component of this inhibitory effect involves the
downstream phosphorylation and inactivation of GSK3β
which in turn regulates the amount of active transcription
factors, CREB and the p65 subunit of NF-κB, that interact
with the common co-activator, CBP, leading to altered
cytokine synthesis.

© 2014 John Wiley & Sons Ltd
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Over the course of our investigations, we have demonstrated that Aggregatibactor actinomycetemcomitans, a
putative pathogen implicated in the aetiology and pathogenesis of localized juvenile periodontitis, produces an
immunotoxin that affects human T-cell responses
(Shenker et al., 1982; 1990; 1999). This toxin was shown
to interfere with normal cell cycle progression resulting in
G2 arrest as well as induction of apoptosis (Shenker
et al., 1995). Moreover, we have shown that the toxin is
the product of the cytolethal distending toxin (Cdt) operon
(Shenker et al., 1999). Cdts are a family of heat-labile
protein cytotoxins produced by several different bacterial
species including diarrhoeal disease-causing enteropathogens such as some Escherichia coli isolates,
Campylobacter jejuni, Shigella species, Haemophilus
ducreyi and A. actinomycetemcomitans (Pickett et al.,
1994; 1996; Okuda et al., 1995; 1997; Comayras et al.,
1997; Mayer et al., 1999; Pickett and Whitehouse, 1999;
Shenker et al., 1999). The Cdt operon contains three
genes: cdtA, cdtB and cdtC which specify three polypeptides with molecular masses of 18, 32 and 20 kDa respectively. The three subunits form a heterotrimeric holotoxin
that functions as an AB2 toxin.
Our studies have focused on Cdt subunit function,
events critical to toxin–cell interaction, fate of Cdt-treated
cells and mode of action by which Cdt induces G2 arrest
and apoptosis. In particular, we have demonstrated that
Cdt subunits A and C comprise the binding unit which
involves recognition and binding by CdtC to cholesterol in
the context of lipid rafts (Boesze-Battaglia et al., 2006;
2009). Other studies have also implicated glycans and
glycoproteins on target cells as a site for toxin binding
(Nesic et al., 2004; Eshraghi et al., 2010). The active
subunit, CdtB, functions as a PIP3 phosphatase mimicking the tumour suppressors, PTEN and SHIP, and is able
to block the PI3K/PIP3/Akt signalling cascade (Shenker
et al., 2007; 2010). We now demonstrate that human
macrophages are not susceptible to Cdt-induced
apoptosis. However, macrophages treated with Cdt
exhibit blockade of PI-3K signalling with a concomitant
increase in GSK3β kinase activity leading to the production of pro-inflammatory cytokines. We propose that in
addition to its ability to function as an immunotoxin
capable of perturbing PI-3K signalling, cell growth and
survival, Cdt also represents a potent virulence factor
capable of blocking PI-3K signalling in macrophages
leading to a pro-inflammatory cytokine response.
Results
Cdt interacts with macrophages and alters
PI-3K signalling
THP-1 cells and human monocytes as well as
macrophages derived from either the THP-1 cell line or

monocytes (monocyte-derived macrophages; MDM) were
initially tested for susceptibility to Cdt-induced apoptosis.
As shown in Fig. 1, cells were incubated in medium alone
or with Cdt for 48 h and then assessed for DNA fragmentation using the TUNEL assay. Cdt (10 ng ml−1) induced
DNA fragmentation in 85.7% of THP-1 cells compared
with 1.3% in the untreated control cells (Fig. 1A and B).
However, when THP-1 cells were treated with PMA and
allowed to differentiate into macrophages for 72 h, they no
longer were susceptible to Cdt as exposure to toxin
(1 μg ml−1) failed to induce significant apoptosis (7.8%;
Fig. 1C and D). It should be noted that differentiated
THP-1 cells exposed to 2.5 μg ml−1 Cdt for up to 72 h also
failed to become apoptotic (data not shown). Neither
human monocytes or MDM were susceptible to Cdtinduced apoptosis as cells treated with Cdt (500 ng ml−1)
for 48 h resulted in DNA fragmentation in 2.6% and
4.5% cells respectively. DNA fragmentation in control
monocytes and MDM was 2.6% and 3.6% respectively
(Fig. 1E–H).
We next determined if Cdt was able to associate with
differentiated THP-1 cells and deliver the active subunit,
CdtB, to intracellular compartments. In this regard, we
have previously demonstrated that Cdt subunits A and C
were responsible for cell association and further, that CdtC
contains a cholesterol recognition/interaction amino acid
consensus sequence (CRAC) critical for toxin binding and
subsequent internalization of CdtB (Boesze-Battaglia
et al., 2009). Internalization of the active subunit, CdtB,
was assessed by flow cytometry following permeabilization and intracellular immunofluorescence staining
for CdtB. As shown in Fig. 2A, cells treated with Cdt
contained detectable levels of intracellular CdtB; mean
channel fluorescence (MCF) was 67 compared to background fluorescence of 6 observed in untreated cells
exposed to medium alone. It should be noted that incubation of cells with toxin at 5°C prevents internalization of
CdtB (MCF = 6; Fig. 2B). We have previously demonstrated that Cdt containing a mutation in the CRAC site,
CdtABCY71P, was unable to bind to lymphocytes and
deliver CdtB to the cell (Boesze-Battaglia et al., 2009).
Similarly, CdtABCY71P exhibited reduced capacity to deliver
CdtB to THP-1-derived macrophages as these cells
exhibit a MCF of 31 (Fig. 2A). We have previously demonstrated that following association with Jurkat cells, CdtB
is rapidly internalized and further, that this subunit is minimally detected on the cell surface. For control purposes,
Cdt-treated THP-1-derived macrophages were also
assessed for surface-associated CdtB (Fig. 2C). The MCF
for surface CdtB was 21demonstrating that most of the
immunofluorescence associated with CdtB results from
staining of the internalized subunit following permeabilization; cells exposed to CdtABCY71P and stained
without permeabilization exhibited a MCF of 13 (Fig. 2C).
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404

14625822, 2014, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/cmi.12299 by University Of Pennsylvania, Wiley Online Library on [19/10/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

1392 B. J. Shenker et al.

1393

Fig. 1. Effect of Cdt on THP-1, monocyte
and macrophage DNA fragmentation. THP-1
cells (panels A and B), THP-1-derived
macrophages (panels C and D), monocytes
(panels E and F) and MDM (panels G and H)
were exposed to medium (panels A, C, E, G)
or treated with Cdt (panels A, C, F, H) for
48 h. THP-1 cells were exposed to 10 ng ml−1
Cdt and THP-1-derived macrophages to
1 μg ml−1 of toxin; monocytes and MDM were
treated with 500 ng ml−1 Cdt. The cells were
then analysed by flow cytometry for the
presence of DNA fragmentation as described
in Experimental procedures. Results are
plotted as relative cell number versus DNA
fragmentation (BrDU-FITC fluorescence). The
line represents the analytical gate used to
assess cells exhibiting DNA fragmentation
and the numbers are the percentage of
positive cells. Results are representative of
three experiments.

As Cdt is capable of binding to macrophages leading to
internalization of CdtB, we next determined if Cdt-treated
macrophages exhibit perturbations in PI-3K signalling
consistent with CdtB’s functioning as a PIP3 phosphatase. In Fig. 3A we demonstrate that monocytes
treated with 200 and 500 ng ml−1 Cdt for 2 h exhibit
reduced levels of PIP3 to 0.15 ± 0.006 and 0.10 ±
0.03 pmol per 106 cells; this compares with 0.22 ±
0.02 pmol per 106 cells in untreated cells. THP-1-derived
macrophages were treated with Cdt (50 ng ml−1) for
0–120 min and then assessed by Western blot for
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404

changes in pAkt and pGSK3β. As shown in Fig. 3B and C,
baseline levels of pAkt(S473) were reduced in Cdt-treated
cells in a time-dependent manner; pAkt levels were significantly reduced to 65 ± 1.5% and 56 ± 3.4% of control
values within 60 and 120 min of exposure to toxin respectively. Reduction in Akt phosphorylation was accompanied
by a concomitant decrease in its kinase activity which was
reduced to 70 ± 7% of control values in the presence of
1 ng ml−1 Cdt after a 2 h exposure (Fig. 4A); kinase activity was further reduced to 49 ± 11.3% in the presence of
10 ng ml−1. A downstream target of pAkt is GSK3β as
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Fig. 2. Immunofluorescence analysis of internalization of CdtB. THP-1-derived macrophages were exposed to media alone (black dotted line),
CdtWT (red line) or CdtABCY71P (green line) for 1 h and then analysed by immunofluorescence and flow cytometry for the presence of CdtB
following fixation, permeabilization and staining with anti-CdtB mAb conjugated to AlexaFluor 488. Panel A shows results of cells incubated at
37°C, fixed, permeabilized and stained for CdtB. Panel B shows results of cells incubated at 5°C and treated as described above. Panel C
shows fluorescence associated with CdtB in non-permeabilized cells incubated at 37°C. Fluorescence is plotted versus relative cell number.
Numbers represent the mean channel fluorescence (MCF); at least 10 000 cells were analysed per sample. Results are representative of
three experiments. The MCF for untreated cells (autofluorescent) was 4.

phosphorylation of this kinase is dependent upon Akt
activity. GSK3β phosphorylation was reduced to 57 ± 11%
and significantly reduced to 37 ± 10% of control levels
at 1 and 2 h respectively (Fig. 3). In contrast to Akt,
dephosphorylation of GSK3β is associated with an
increase in kinase activity. Indeed, Cdt-treated macrophages exhibited a 1.4-fold increase in GSK3β kinase
activity in the presence of 1 ng ml−1 Cdt after 2 h exposure; activity continued to increase by 1.7- and 2.2-fold in
cells exposed to 10 ng ml−1 and 100 ng ml−1 of toxin
respectively (Fig. 4B).
Cdt induces a pro-inflammatory response
from macrophages
Although macrophages are resistant to Cdt-induced
apoptosis, it is clear that the toxin is able to associate with
these cells, deliver CdtB and perturb the PI-3K signalling
pathway in a manner consistent with the action of a PIP3
phosphatase. While the PI-3K signalling pathway is not
considered to be directly involved in signal pathways
leading to cytokine synthesis and release, it is becoming
clear that this pathway plays a regulatory role that can
influence cytokine production from macrophages at
rest or following activation by TLR agonists (Guha and
Mackman, 2002; Hazeki et al., 2007; Molnarfi et al.,
2007). Therefore, we next assessed Cdt for its ability to
induce macrophages to express mRNA for three proinflammatory cytokines: IL-1β, TNFα and IL-6. Differentiated THP-1 cells were treated with varying amounts of Cdt
(0–200 ng ml−1) for 2 h and cytokine mRNA levels were
assessed by quantitative real-time PCR (Fig. 5A). Exposure to the lowest dose of Cdt (8 ng ml−1) resulted in
> 80-fold increase in mRNA levels for IL-1β, TNFα and
IL-6. Exposure to 200 ng ml−1 Cdt resulted in further

increases of > 120-fold for IL-1β and TNFα along with
> 24 000-fold increase for IL-6. MDM also exhibited > 10fold increases in the levels of mRNA for each of these
cytokines when treated with 8–200 ng ml−1 of Cdt
(Fig. 5B).
In the next series of experiments we determined
if increased expression of cytokine mRNA was accompanied by increased cytokine release. As shown in
Fig. 6A, untreated THP-1 derived-macrophages released
low levels of IL-1β (41.1 ± 4.2 pg ml−1) and TNFα
(171.1 ± 17); IL-6 was undetectable in supernatants. In
contrast, macrophages were induced to release cytokines
within 5 h of exposure to Cdt. IL-1β release was dosedependent as exposure to 8 ng ml−1 Cdt resulted in
release of 209 ± 44 pg ml−1; increasing the dose of
toxin to 40 and 200 ng ml−1 induced 264 ± 12 and
499 ± 58 pg ml−1 of cytokine respectively. Likewise, the
toxin induced dose-dependent release of both TNFα and
IL-6 (Fig. 6B and C). Cells exposed to 8 ng ml−1 Cdt
induced 983 ± 372 pg ml−1 TNFα and 101 ± 60 pg ml−1
IL-6; increasing the dose of toxin to 200 ng ml−1 resulted in
4482 ± 1738 and 425 ± 142 pg ml−1 of TNFα and IL-6
respectively. It is also noteworthy that toxin containing the
CRAC mutation, CdtABCY71P, not only exhibited reduced
ability to deliver CdtB, but also decreased ability to induce
cytokine release (Fig. 7). Cells exposed to 8, 40 and
200 ng ml−1 CdtABCY71P secreted 153 ± 13, 283 ± 23 and
404 ± 51 pg ml−1 IL-1β respectively; this compares to
244 ± 15, 463 ± 13 and 651 ± 39 pg ml−1 IL-1β from cells
treated with CdtWT. Similar results were observed for
TNFα: cells exposed to CdtABCY71P released 331 ± 52
(8 pg ml−1), 645 ± 91 (40 pg ml−1) and 942 ± 106 compared to 655 ± 123, 1019 ± 77 and 1752 ± 122 pg ml−1 in
cells treated with 8, 40 and 200 ng ml−1 CdtWT respectively
(Fig. 7).
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404
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8 ng ml Cdt induced the release of both TNFα and IL-6,
249 ± 74 and 54 ± 22 pg ml−1 respectively; in the presence of 200 ng ml−1, these values increased to 473 ± 118
and 213 ± 33 pg ml−1 respectively. Control cells released
93 pg ml−1 (TNFα) and 5 (IL-6) pg ml−1.

Fig. 3. Effect of Cdt on downstream components of the PI-3K
signalling pathway. Monocytes were treated with Cdt and then
assessed for levels of PIP3 (panel A). Results are the mean ± S.E.
for three experiments. The effect of Cdt on Akt and GSK3β
phosphorylation is shown in panels B and C. THP-1-derived
macrophages were exposed to 50 ng ml−1 of Cdt for 0–120 min
then harvested, solubilized and fractionated by SDS-PAGE. Gels
were analysed by Western blot for the presence of Akt, pAkt(S473),
GSK3β and pGSK3β(S9) followed by digital scanning densitometry;
actin is shown as a loading control. A representative Western blot
is shown in panel B and the mean ± SEM is shown for three
experiments in panel C. Asterisks indicate P < 0.05 when compared
to untreated cells.

In addition to THP-1-derived cells, Cdt was also
assessed for its ability to induce cytokine release from
MDM (Fig. 6A–C). Twenty-four-hour exposure to Cdt
induced MDM release of IL-1β in a dose-dependent
manner (0–200 ng ml−1); 50 ± 5 pg IL-1β was released in
the presence of 8 ng ml−1 of toxin and increased to
74 ± 7 pg ml−1 in the presence of 200 ng ml−1 while control
cells released 34 ± 5 pg ml−1. Similarly, exposure to
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404

Fig. 4. Analysis of the effect of Cdt on Akt and GSK3β kinase
activity. THP-1-derived macrophages were treated with 1.0, 10 and
100 ng ml−1 Cdt for 2 h. Total Akt was immunoprecipitated from
solubilized cells and kinase activity measured by monitoring GSK3β
phosphorylation in vitro. Western blots were analysed by digital
scanning densitometry and values expressed as a percentage
of control; results are plotted as the mean ± SEM of three
experiments (panel A). GSK3β was immunoprecipitated and kinase
activity was measured in similarly treated cells by monitoring the
utilization 32P-ATP to phosphorylate a synthetic substrate. Data are
plotted as 32P (cpm) incorporation versus Cdt concentration; results
represent the mean ± SEM for three experiments. Asterisks indicate
P < 0.05 when compared to untreated cells. Panel C shows the
recovery of Akt and GSK3β from representative immunoprecipitates
assessed by Western blot.
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Fig. 5. Effect of Cdt on IL-1β, TNFα and IL-6 gene expression.
THP-1-derived macrophages (panel A) and MDM (panel B) were
treated with varying concentrations of Cdt for 2 h. Total RNA was
collected and analysed for IL-1β (open bars), TNFα (striped bars)
and IL-6 (solid bars) gene expression using RT-PCR as described
in Experimental procedures. Results are the mean ± SEM for three
experiments.

To further demonstrate that the Cdt-induced proinflammatory cytokine response was dependent upon
CdtB associated PIP3 phosphatase activity, we employed
toxin containing CdtB mutants in addition to wild-type
toxin. Three CdtB mutants involving amino acid substitutions in residues that correspond to the putative active site
and likely to be involved in substrate binding were
employed: CdtBA163R, CdtBR144A and CdtBN201A. It should be
noted that we have previously shown that CdtBA163R
retains PIP3 phosphatase activity while the other two
mutants exhibit significantly reduced phosphatase activity
(B.J. Shenker, unpublished). As shown in Fig. 8, toxin
containing the CdtBA163R mutation induced both IL-1β and
TNFα release from THP-1-derived macrophages in a
dose-dependent manner. In the presence of 20 ng ml−1
CdtBA163R, cells released 223 ± 23 pg ml−1 IL-1β and
547 ± 134 pg ml−1 TNFα; this compares to 352 ± 12
and 738 ± 89 pg ml−1 for CdtBWT respectively. Cytokine
release in the presence of 100 ng ml−1 CdtBA163R resulted
in 1294 ± 17 (IL-1β) and 2465 ± 502 (TNFα) compared

to 1524 ± 99 (IL-1β) and 3080 ± 458 (TNFα) pg ml−1
for cells exposed to CdtBWT. In contrast, cells exposed to
the CdtB mutants, CdtBR144A and CdtBN201A, released
lower amounts of cytokines. For example, exposure to
100 ng ml−1 Cdt resulted in 503 ± 16 (CdtBR144A) and
171 ± 66 ( CdtBN201A) pg ml−1 IL-1β; exposure to these
mutants resulted in reduced TNFα production as
well: 1237 ± 391 (CdtBR144A) and 1252 ± 298 pg ml−1
(CdtBN201A).
As discussed above, the PI-3K signalling pathway has
been implicated as a regulator of the pro-inflammatory
response of macrophages to TLR agonists. Therefore, we
next assessed Cdt for its ability to augment the proinflammatory cytokine response induced by three TLR
agonists: LPS (TLR4), PAM3CSK4 (TLR2) and poly
I:C (TLR3). As shown in Fig. 9, exposure of THP-1derived macrophages to varying amounts of Cdt
(0–200 ng ml−1) augmented LPS-induced release of IL-1β
in a dose-dependent manner; cells treated with 8 ng ml−1
toxin released 2032 ± 332 pg ml−1 versus 1248 ± 170 pg
in cells treated with LPS alone. These values increased
to 2362 ± 261 and 2683 ± 230 pg ml−1 in the presence of
40 and 200 ng ml−1 Cdt respectively. THP-1-derived
macrophages activated by PAM3CSK4 showed similar
effects. The maximum effect of the toxin on PAM3CSK4induced IL-1β release was observed with 8 ng ml−1 Cdt
resulting in 776 ± 168 pg ml−1 versus 464 ± 100 pg ml−1
in cells exposed to PAM3CSK4 alone; these values
remained elevated in the presence of 200 ng ml−1 Cdt at
610 ± 133 pg ml−1. Likewise, the toxin enhanced IL-1β
release induced by the intracellular TLR2 agonist poly I:C;
cells exposed to agonist alone secreted 396 ± 47 pg ml−1
of cytokine versus 752 ± 4 and 1009 ± 28 pg ml−1 in the
presence of 40 and 200 ng ml−1 Cdt respectively. The
dose-dependent effect of Cdt on TLR agonist-induced
cytokine release from MDM was also assessed and found
to be significantly increased in the presence of toxin.
LPS-induced IL-1β secretion was maximally increased in
the presence of 200 ng ml−1 Cdt resulting in a 2.9-fold
increase over LPS control, 3.1-fold increase over
PAM3CSK4 control and a 23-fold increase over poly I:C
control. Similar results were observed for TNFα with
both MDM and THP-1-derived macrophages (data not
shown).
In the last series of experiments we addressed the
mechanism by which Cdt-mediated perturbation of the
PI-3K/PIP3/Akt signalling cascade leads to synthesis and
release of pro-inflammatory cytokines. As discussed
earlier, there is evidence supporting the notion that the
PI-3K pathway is a negative feedback regulator of the
synthesis and release of pro-inflammatory cytokines by
macrophages. A key component of this inhibitory effect
involves the downstream inactivation of GSK3β (i.e.
phosphorylation); it has been proposed that inactivation of
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404
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Fig. 6. Cdt induces macrophages to release
pro-inflammatory cytokines. THP-1-derived
macrophages (hatched bars) and MDM (solid
bars) were treated with Cdt (0–200 ng ml−1)
and the supernatants analysed 5 h (THP-1) or
24 h (MDM) later by ELISA for IL-1β (panel
A), TNFα (panel B) and IL-6 (panel C).
Results are the mean ± SEM for three
experiments each performed in triplicate;
asterisks indicate P < 0.05 when compared to
untreated cells.

the kinase influences the amount of active transcription
factors, CREB and p65 subunit of NF-κB, which interact
with the common co-activator CBP leading to altered
cytokine synthesis (Guha and Mackman, 2002;
Hazeki et al., 2007). Likewise, it has been suggested
that inactivation of the PI-3K signalling pathway results
in decreased phosphorylation of GSK3β leading to
increased kinase activity, and in turn, kinase-dependent
changes in NF-κB-dependent expression of proinflammatory cytokines. We have demonstrated that Cdt© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404

treated macrophages exhibit reduced levels of pGSK3β
and increased kinase activity. Therefore, we extended
this observation and employed five inhibitors of GSK3β.
As shown in Fig. 10, all inhibitors reduced levels
of Cdt-induced TNFα release. Cells treated with Cdt
alone released 2131 ± 258 pg ml−1 TNFα compared to
197 ± 24 pg ml−1 in untreated control cells. TNFα release
was reduced in cells pre-treated with inhibitor to 146 ± 64
(LiCl), 1075 ± 125 (SB216763), 501 ± 240 (GSK X inhibitor), 678 ± 144 (GSK XII inhibitor) and to 440 ± 46 (GSK
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Fig. 7. Effect of CdtC CRAC mutant on cytokine release.
THP-1-derived macrophages were treated with CdtABCWT or
CdtABCY71P for 5 h. Supernatants were analysed by ELISA for IL-1β
and TNFα. Results are the mean ± SEM for three experiments
each performed in triplicate; asterisk indicates statistical
significance (P < 0.05) when compared to CdtABCWT at the same
concentration.

toxin for extended periods of time did not result in
apoptosis. This observation is consistent with our previous studies in which we demonstrated that non-activated
lymphocytes, i.e. cells that are not proliferating, are also
not susceptible to Cdt-induced apoptosis (Shenker et al.,
2001). It should be noted that undifferentiated, proliferating THP-1 cells are susceptible to both Cdt-induced cell
cycle arrest (data not shown) and apoptosis. Our results
are different from those of Rabin et al. (2009) who previously reported that macrophages-derived from the U937
myeloid leukaemia cell line were susceptible to Cdtinduced apoptosis. It is possible that the discrepancy
between our observations and Rabin et al. (2009) represents subtle differences between macrophages-derived
from THP-1 versus U937 leukaemic cell lines. Indeed,
Baird et al. (2005) have reported differential susceptibility
to apoptotic stimuli between these cells. Moreover, Rabin
et al. (2009) also reported that Cdt-treated U937-derived
macrophages failed to exhibit caspase-3 activation, thus it
is possible that they were studying an entirely different

XV inhibitor).We also employed the inhibitor Bay11-7062
to block downstream activation of NF-κB. As shown in
Fig. 10, cytokine release from cells treated with Bay117062 (50 μM ) exhibited reduced levels of TNFα
(433 ± 85 pg ml−1).
Discussion
The Cdts are a family of heat-labile protein cytotoxins
produced by several different bacterial species which
were originally characterized by their ability to cause progressive cellular distension and finally death in some cell
lines (reviewed in Guerra et al., 2011). It should be noted
that the gross cellular changes associated with Cdt activity are clearly different from those caused by other
known toxins that induce rapid morphological alterations
culminating in cell death (Aragon et al., 1997; Cope
et al., 1997; Lally et al., 1997). More recently, it has
become clear that exposure to Cdt induces proliferating
cells to undergo irreversible G2 arrest which eventually
culminates in cell death resulting from activation of the
apoptotic cascade (Gelfanova et al., 1999; Cortes-Bratti
et al., 2001; Shenker et al., 2001; Ohara et al., 2004).
Indeed, we have demonstrated that activated lymphocytes and lymphocytic cell lines exhibit heightened sensitivity to both Cdt-induced G2 arrest and apoptosis
leading us to propose that the toxin functions as an
immunotoxin (Shenker et al., 2000; 2001; 2004; 2005;
2006).
We now demonstrate that macrophages, both MDM
and THP-1 derived-macrophages, are resistant to Cdtinduced cell death as exposure to high concentrations of

Fig. 8. Analysis of CdtB mutants for their ability to induce cytokine
release. THP-1-derived macrophages were treated for 5 h with
50 ng ml−1 each of CdtA and CdtC along with varying amounts of
CdtBWT, CdtBA163R, CdtBR144A or CdtBN201 mutants. Supernatants
were then analysed for IL-1β (panel A) and TNFα (panel B).
Results are the mean ± SEM for three experiments each performed
in triplicate; asterisk indicates statistical significance (P < 0.05)
when compared to CdtBWT at the same concentration.
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404
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Fig. 9. Cdt augments macrophage response to TLR agonist stimulation. THP-1-derived macrophages (panel A) and MDM (panel B) were
pre-treated with varying amounts of Cdt for 1 h; cells were then exposed to LPS, PAM3CSK4 or poly I:C for 5 h (THP-1-derived macrophages)
or 24 h (MDM). Supernatants were analysed by ELISA for IL-1β. Results are the mean ± SEM for three experiments each performed in
triplicate; asterisks indicate P < 0.05 when compared to untreated cells.

biological process. In addition to cell lines, we have
extended our study to include both primary human blood
monocytes and MDM which we also have found to be
resistant to Cdt-induced apoptosis. It is particularly noteworthy and relevant to our observations those reported by
Busca et al. (2012) who demonstrated that MDM and
THP-1-derived macrophages also exhibit heightened
resistance to Vpr, a potent apoptosis inducing agent

Fig. 10. Effect of GSK3β and NF-κβ inhibitors on Cdt-induced
cytokine release. THP-1-derived macrophages were pre-exposed to
LiCl, SB216763, GSK X inhibitor, GSK XII inhibitor, GSK XV
inhibitor or Bay11-7082 (50 μM) for 30 min followed by the addition
of Cdt (50 ng ml−1). Five hours later supernatants were harvested
and analysed for TNFα by ELISA. Results are the mean ± SEM of
three experiments. Asterisk indicates statistical significance
(P < 0.05) when compared to cells exposed to Cdt alone.
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404

derived from HIV. Thus, the ability of macrophages to
resist Cdt-induced apoptosis is not unique and likely a
consequence of maturation changes that also lead to
protection from other stimuli as well.
In this study, we also demonstrate that Cdt is capable of
interacting with macrophages in a manner similar to lymphocytes as it associates with cells and delivers the active
subunit, CdtB, to intracellular compartments; these interactions are dependent upon a competent cholesterol recognition sequence, CRAC site, within the CdtC subunit.
Although macrophages are resistant to Cdt-induced
apoptosis, we now demonstrate that MDM and THP-1derived macrophages are susceptible to Cdt-induced production of inflammatory cytokines including IL-1β, TNFα
and IL-6. Moreover, the toxin is capable of augmenting
cytokine production by macrophages in response to
TLR-2, -3 and -4 agonists. Similar cytokine responses
were also observed from undifferentiated monocytes
(data not shown). It should be noted that Cdt preparations
are highly purified and it is unlikely that these effects are
the result of a contaminant unrelated to toxin. Nonetheless, the CdtABCY71P mutant with reduced binding capability also exhibited reduced ability to stimulate cytokine
production and serves as a control for this possibility. In
contrast to our observations, Xu et al. (2004) failed to
observe an increase in IL-1β production from Cdt-treated
monocyte-derived dendritic cells. At this point we can only
speculate that this contradictory observation may relate to
differences in differentiation pathways.
Previously, we demonstrated that the active Cdt
subunit, CdtB, was capable of functioning as a PIP3 phosphatase leading to perturbation of the PI-3K signalling
pathway; this activity appears to be critical to toxininduced G2 arrest in lymphocytes and inhibition of mast
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cell degranulation (Shenker et al., 2007; 2010; 2011). In
our current study, we also demonstrate that Cdt-treated
macrophages exhibit perturbations in the PI-3K signalling
pathway consistent with the action of a PIP3 phosphatase: decreased levels of PIP3 and reduced
phosphorylation of both Akt and GSK3β. These changes
in phosphorylation status were accompanied by altered
kinase activity; Akt activity was decreased while GSK3β
kinase activity increased. We propose that the Cdtinduced pro-inflammatory cytokine response was the
result of CdtB’s lipid phosphatase activity; this conclusion
is drawn from two results. First, we employed toxin containing three CdtB containing mutants with altered enzymatic activity: CdtBA163R mutant retains PIP3 phosphatase
activity comparable to CdtBWT and induces macrophages
to produce cytokines at levels comparable to the wild-type
toxin. In contrast, the CdtBR144A and CdtBN201A mutants
both have significantly reduced phosphatase activity and,
likewise, exhibit reduced ability to induce macrophages to
release IL-1β, TNFα and IL-6. The second line of evidence in support of PIP3 phosphatase activity being critical to Cdt-induced cytokine release is derived from the
use of several GSK3β inhibitors. It is well documented that
inactivation of PI-3K signalling leads to decreased PIP3
and pAkt levels resulting in decreased phosphorylation of
GSK3β and concomitant increases in its kinase activity. In
addition to demonstrating that Cdt-treated cells exhibit
increased GSK3β activity, we also demonstrate that the
GSK3β inhibitors suppressed Cdt-induced cytokine
release.
The studies described in this report provide critical
insight into the molecular mechanism by which Cdt acts to
promote a pro-inflammatory response as well as advance
our understanding of the regulatory role of the PI-3K
pathway in governing these responses (summarized in
Fig. 11). In this regard, a relationship between TLRsignalling and the PI-3K pathway in macrophages was
first established by Arbibe et al. (2000) who demonstrated
that TLR-2 signalling involves interaction with components of the PI-3K cascade. Over the last several years it
has also become increasingly clear that the PI-3K signalling pathway plays a regulatory role that governs cytokine
production (Arbibe et al., 2000; Guha and Mackman,
2002; Fang et al., 2004; Hazeki et al., 2007; Molnarfi
et al., 2007; Brown et al., 2010; Antoniv and Ivashkiv,
2011). Specifically, activation of the pathway reduces the
release of pro-inflammatory cytokines, likely serving to
dampen inflammatory responses. In contrast, inactivation
of PI-3K signalling leads to elevated production of proinflammatory cytokines and concomitant chronic inflammation. Additionally, it has recently been shown that the
activation of the downstream PI-3K targets, GSK3β and
mTORC1 are most likely involved in regulating NF-κB
activation and, thereby, the pro-inflammatory response

Fig. 11. Schematic summary indicating the mechanism by which
Cdt, specifically CdtB, affects the PI-3K signalling pathway and the
production of pro-inflammatory cytokines. The effects of CdtB on
PI-3K signalling is shown in red. Exposure to the toxin results in
degradation of PIP3 and reduced phosphorylation of both GSK3β
and Akt and an increase in kinase activity of the former. GSK3β
influences pro-inflammatory cytokine expression by modifying
NF-κβ activation by influencing p65 subunit association with the
common co-activator, CBP. The blue and green bars indicate the
ability of GSK3β (blue) and NF-κβ (green) inhibitors to block the
pro-inflammatory effects of Cdt.

(Ohtani et al., 2008; Wang et al., 2008; Weichhart et al.,
2008). Indeed, we demonstrate that in addition to GSK3β
inhibitors discussed above, Bay11-7082, a NF-κB inhibitor, also blocks the pro-inflammatory effects of Cdt. Of
particular relevance to our study are the findings of Fang
et al. (2004) who studied the role of SHIP, a PIP3 phosphatase, on macrophage cytokine production. Indeed,
they demonstrated that SHIP expression in deficient cells
could reverse Akt activation and in turn, lead to increased
cytokine production in response to LPS. Likewise,
Schabbauer et al. (Fang et al., 2004; Schabbauer et al.,
2010) demonstrated that the absence of another PIP3
phosphatase, PTEN, lead to PI-3K activation and
decreased inflammation in vivo. Our studies with the
bacterial-derived PIP3 phosphatase, CdtB, provides
further support for the role of PI-3K signalling in regulating
IL-1β, TNFα and IL-6 production as exposure to the toxin
blocked PI-3K signalling and resulted in increased
cytokine production by macrophages at rest as well as in
the presence of TLR agonists. Moreover, we demonstrate
that this regulatory control involves a signalling pathway
common to multiple TLRs (TLR-2, TLR-3 and TLR-4).
These studies provide crucial insight into the molecular
mechanism by which Cdt acts to perturb host responses
and thereby promote disease associated with Cdtproducing organisms. A critical question that will need to
be addressed in future studies is whether these proinflammatory in vitro effects are the result of biologically
relevant quantities of Cdt? To date there are no estimates
of the Cdt load in infected tissues; however, it is important
to note that our observations occur at Cdt concentrations
that are several orders of magnitude lower than those
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404
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reported for the induction of apoptosis and/or cell cycle
arrest in a number of cell types in vitro (Cortes-Bratti et al.,
2001; Elwell et al., 2001; Nesic et al., 2004). Furthermore,
our observations are consistent with the pathogenesis of
inflammatory disorders that result from infection by Cdtproducing organisms such as A. actinomycetemcomitans.
For example, periodontal disease is a bacterial-induced
inflammatory disorder leading to the destruction of the
tooth-supporting tissues. A common finding of both
experimental and clinical investigations is the presence of
elevated levels of pro-inflammatory cytokines in and
around the damaged periodontium (Andrukhov et al.,
2011; Fredman et al., 2011; Bezerra et al., 2012;
Hajishengallis et al., 2012). Moreover, it has been suggested that the inflammatory destruction of tissue generates both degraded proteins and haemin which serve to
fuel the nutritional needs of the bacteria and thereby
promote bacterial growth and survival and further exacerbate inflammation (Hajishengallis et al., 2012)
In conclusion, our observations clearly demonstrate
that Cdt is capable of interacting with macrophages,
promote a pro-inflammatory cytokine response and
thereby may contribute to persistent infection and inflammation. These effects are mediated at the molecular level
by the action of the active Cdt subunit, CdtB, functioning
as a PIP3 phosphatase leading to blockade of the PI-3K
signalling pathway. In contrast, the acquired immune
system is also affected by Cdt via effects on PI-3K signalling; specifically, treatment of activated lymphocytes
with Cdt results in cell cycle arrest (G2) and apoptosis.
This effect would likely prevent a productive immune
response against the toxin, and possibly to microorganism(s) as well, leading to conditions that sustain infection
and further promote inflammation. We anticipate that
future studies will provide further insight into these in vitro
relationships and the in vivo interactions that ultimately
contribute to the pathogenesis of disease involving Cdtproducing bacteria.
Experimental procedures
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FlowComp Human CD14; Invitrogen). Anti-CD14 mAb-bead
complexes were removed from the positively selected
monocytes using a release buffer (Invitrogen). Monocytes were
routinely found to be > 96% pure as determined by
immunofluorescent staining and analysed by flow cytometry.
Monocyte-derived macrophages (MDM) were generated by incubating monocytes in DMEM containing 10% fetal bovine serum
and 2% penicillin/streptomycin for 6–8 days.
THP-1-derived macrophages and MDM were treated with
recombinant Cdt holotoxin (both wild-type and mutant) or with
individual Cdt subunits (including CdtBWT and CdtB mutants)
which were expressed and purified as previously described
(Shenker et al., 2004; Shenker et al., 2007). In some experiments, cells were also exposed to TLR agonists: LPS (E. coli
0111:B4; Calbiochem), PAM3CSK4 (Invivogen) or poly I:C
(Invivogen). Five GSK3β inhibitors were employed: LiCl (SigmaAldrich), SB216763 (Enzo), GSK X inhibitor (Santa Cruz), GSK
XII inhibitor (Santa Cruz) and GSK XV inhibitor (Calbiochem) as
well the NF-κB inhibitor, Bay-ll-7062 (Invivogen).

Analysis of DNA fragmentation and
immunofluorescence
THP-1 cells and THP-1-derived macrophages (5 × 105) were
prepared as described above and then treated with Cdt for
48 h. Cells were harvested by replacing medium with ice-cold
PBS containing 5 mM EDTA. Likewise, monocytes or MDM
(1 × 106) were incubated with Cdt for 48 h; cells were collected
following trypsinization. DNA fragmentation was measured
using the TUNEL assay [In Situ Cell Death Detection Kit
(Boehringer Mannheim)] (Shenker et al., 2006). Cells were harvested and re-suspended in 1 ml of freshly prepared 4% formaldehyde and permeabilized in 0.1% Triton X-100 for 2 min at
4°C. The cells were then washed with PBS and incubated in a
solution containing FITC-labelled nucleotide and terminal
deoxynucleotidyl transferase (TdT) according to the manufacturers specifications. FITC fluorescence was assessed by flow
cytometry using an argon laser at 488 nm to excite the
fluorochrome; emission was measured through a 530/30 nm
bandpass filter.
Intracellular CdtB was monitored in cells (1 × 106) incubated
for 1 h in the presence of medium or 2 μg ml−1 of CdtABCwt
or CdtABCY71P at 37°C or 5°C. Intracellular CdtB was detected
following fixation with 2% formaldehyde for 30 min,
permeabilization with 0.1% Triton X-100 in 0.1% sodium citrate
and stained with anti-CdtB mAb conjugated to AlexaFluor 488
(Molecular Probes).

Cells and reagents
The human acute monocytic leukaemia cell line, THP-1,
was obtained from ATCC; cells were maintained in RPMI
1640-containing 10% FBS, 1 mM sodium pyruvate, 20 μM
2-mercaptoethanol and 2% penicillin-streptomycin at 37°C with
5% CO2 in a humidified incubator. THP-1 cells were differentiated
into macrophages by incubating cells in the presence of
50 ng ml−1 PMA for 48 h at which time the cells were washed and
incubated an additional 24 h in medium prior to use.
Human peripheral blood mononuclear cells (HPBMC) were
obtained from venous blood of healthy donors as previously
described (Shenker et al., 2004). Monocytes were further purified from HPBMC by positive selection using anti-CD14 mAb
according to the manufacturers directions (Dynabeads®
© 2014 John Wiley & Sons Ltd, Cellular Microbiology, 16, 1391–1404

Measurement of cytokine mRNA by RT-PCR
THP-1-derived macrophages or MDM (1 × 106) were prepared
and treated as described above for 2 h. RNA was extracted from
cells using a commercially available kit (RNeasy; Qiagen).
RT-PCR was employed to measure relative mRNA levels for
IL-1β, TNFα and IL-6. Briefly, cDNA synthesis was performed
using a commercially available kit and according to the manufacturers specifications (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems). RT-PCR was performed on
an ABI Fast Real-Time PCR System using TaqMan sequencespecific probes (Invitrogen). The fold increase in mRNA was
calculated according to the method described by Livak and
Schmittgen (2001).
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Measurement of cytokine production

Statistical analysis

Cytokine production was measured in THP-1-derived macrophages (2 × 105 cells) and MDM (1 × 106 cells) incubated for 5 h
and 24 h respectively. Culture supernatants were collected and
analysed by ELISA for IL-1β (Quantikine Elisa Kit; R and D
Systems), TNFα (Peprotech) and IL-6 (Peprotech) using commercially available kits according to the manufacturer’s instructions. In each instance, the amount of cytokine present in the
supernatant was determined using a standard curve.

Mean ± standard error of the mean were calculated for replicate
experiments. Significance was determined using a Student’s
t-test; a P-value of less than 0.05 was considered to be statistically significant.

Analysis of Akt and GSK3β phosphorylation status and
kinase activity
Replicate wells of THP-1-derived macrophages (1 × 10 cells per
well) were incubated as described with Cdt. The cells were
washed and treated with 20 mM Tris-HCl buffer (pH 7.5) containing 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1% sodium
deoxycholate and protease and phosphatase inhibitors (Pierce );
replicate wells were pooled and protein concentration determined. Samples (30 μg) were separated on 12% SDS-PAGE and
then transferred to nitrocellulose. The membrane was blocked
with BLOTTO and then incubated with one of the following
primary antibodies for 18 h at 4°C (Shenker et al., 1999): antipAkt (S473) and anti-pGSK (S9) (Cell Signaling). Membranes
were washed, incubated with goat anti-mouse immunoglobulin
[1:1000 dilution (Southern Biotech)] conjugated to horseradish
peroxidase. The Western blots were developed using chemiluminescence and analysed by digital densitometry (Kodak Image
Systems) as previously described (Shenker et al., 2010).
Akt- and GSK3β-specific kinase activity was assessed in
control and Cdt-treated cells. THP-1-derived macrophages
(2 × 106) were treated with Cdt as described; replicate cultures
pooled and solubilized. Akt activity was measured using a commercially available assay kit (Cell Signaling Technology). Briefly,
pAkt was immunoprecipitated and the enzyme was assessed for
its ability to phosphorylate GSK3β in vitro; activity was monitored
by Western blot as described above. GSK3β kinase activity was
also measured using a commercially available kit (Sigma Chemical Co). The kinase was immunoprecipitated and activity determined by following the utilization of 32P-ATP to phosphorylate a
synthetic substrate.
6

Measurement of cellular PIP3 content
Cells (1 × 106 ml−1) were incubated in the presence of medium or
Cdt for 0–240 min. Replicate cultures (0.5–1 × 107 cells) were
pooled and harvested. The cell pellet was treated with cold 0.5
TCA for 5 min, centrifuged and the pellet washed twice with 5%
TCA containing 1 mM EDTA. Neutral lipids were extracted twice
with methanol:chloroform (2:1) at RT. Acidic lipids were extracted
with methanol:chloroform:12M HCl (80:40:1) for 15 min at RT; the
samples were centrifuged for 5 min and the supernatant recovered. The supernatant was then treated with 0.75 ml chloroform
and 0.1 M HCl and centrifuged to separate organic and aqueous
phases; the organic phase was collected and dried. The dried
lipids were resuspended in 120 μl 50 mM Hepes buffer (pH 7.4)
containing 150 mM NaCl and 1.5% sodium cholate, and left
overnight at 4°C. PI-3,4,5-P3 levels were then determined using
commercially available competitive ELISA according to the
manufacturers directions (Echelon).
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